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AbsTrACT
Disease processes that frequently require emergency care 
constitute approximately 50% of the total disease burden 
in low-income and middle-income countries (LMICs). 
Many LMICs continue to deal with emergencies caused 
by communicable disease states such as pneumonia, 
diarrhoea, malaria and meningitis, while also experiencing 
a marked increase in non-communicable diseases, such as 
cardiovascular diseases, diabetes mellitus and trauma. For 
many of these states, emergency care interventions have 
been developed through research in high-income countries 
(HICs) and advances in care have been achieved. However, 
in LMICs, clinical research, especially interventional 
trials, in emergency care are rare. Furthermore, there 
exists minimal research on the emergency management 
of diseases, which are rarely encountered in HICs but 
impact the majority of LMIC populations. This paper 
explores challenges in conducting clinical research in 
patients with emergency conditions in LMICs, identifies 
examples of successful clinical research and highlights the 
system, individual and study design characteristics that 
made such research possible in LMICs. Derived from the 
available literature, a focused list of high impact research 
considerations are put forth.
bACkground
The burden of critical illness and injury in 
low-income and middle-income countries 
(LMICs) is larger than in the higher-resource 
settings.1 2 Research focused on improving 
outcomes early in the presentation of acute, 
potentially life-threatening or therapeutically 
responsive disease processes could substan-
tially reduce LMIC morbidity and mortality. 
Emergency care clinical research has a signif-
icant role in such care transformations. The 
goal of the Collaborative for Enhancing 
Emergency Care Research in LMICs 
(CLEER) project was to identify barriers to 
clinical research in emergency care in LMICs, 
propose solutions and recommend high 
impact clinical research priorities that have 
the potential to impact global public health.
Emergency department (ED) mortality in 
LMICs is high, with mortality occurring in 
1.8% (IQR 0.2%–5.1%) of overall cases and 
4.8% (IQR 2.3%–8.4%) of paediatric cases.3 
Injuries and infectious diseases4 contribute 
the highest morbidity burden. Injury alone 
accounts for ~5 million deaths annually; a 
magnitude 1.7 times greater than the number 
of fatalities from HIV, tuberculosis and malaria 
combined.5 Sepsis, a common final pathway of 
infectious diseases in life-threatening presen-
tations, warrants special consideration in 
LMICs which account for the majority of the 
>30 million global cases annually.6 Addition-
ally, initial presentations and complications of 
non-communicable diseases such as diabetes 
mellitus, hypertension and cerebrovascular 
summary box
 ► There is a paucity of high-quality research on the 
emergency management of diseases, which are 
rarely encountered in high-income countries (HICs) 
but impact the majority of populations in low-income 
and middle-income countries (LMICs).
 ► Emergency care clinical research has substantial 
potential to impact overall morbidity and mortality 
in LMICs.
 ► Addressable constraints to conducting clinical emer-
gency care research in LMICs include: (1) lack of rel-
evant and reproducible measures; (2) resource and 
capacity barriers; (3) ethical constraints and (4) dis-
connect in recognised emergency care dimensions.
 ► The following aspects should be considered to 
conduct high-quality and relevant emergency care 
clinical research in and for LMICs: (1) utilisation of 
standardised, relevant and clinically credible mea-
sures; (2) focus on local capacity building, use of 
technology and collaboration; (3) increased financial 
and non-financial support must be prioritised; (4) 
studies must focus on setting specific emergency 
disease burdens and (5) translation of research find-
ings into practice and policy through education and 
engagement of local stakeholders is required.
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disease are rising and will continue to increase health 
burdens in LMICs.7 8 Continued and broadened research 
in the resuscitation and management of injury, the early 
recognition and treatment of infectious diseases and 
complications of non-communicable diseases has poten-
tial to improve health outcomes in LMICs.
There are several constraints and barriers to this effort. 
These include inadequate resources, lack of staff support 
and underdeveloped research infrastructure for scientific 
endeavours. Applying care guidelines from high-income 
countries (HICs) to LMICs is constrained by insufficient 
data and heterogeneity of resources and practice. Further-
more, LMIC patient populations are relatively young, 
more often critically ill, and have higher age-matched 
mortality than HIC emergency patients.3 The differences 
in resources, organisation, epidemiology, and practice all 
suggest that investment in research in LMICs will make 
emergency care more effective, responsive, and appro-
priate for LMIC populations. Through improvements in 
data collection and implementation of high-quality clin-
ical studies, researchers in LMICs may develop cost-effec-
tive, disease specific and locally relevant interventions. 
The focus of this paper is to identify challenges and 
propose strategies for conducting clinical research in 
LMICs, while highlighting key areas and implementation 
considerations for future clinical research.
EmErgEnCy CArE rEsEArCH in LmiCs: CHALLEngEs And 
sTrATEgiEs
research metrics
Consistently applied, relevant and reproducible meas-
ures are required for emergency care research in LMICs 
to demonstrate high impact and to improve practice both 
locally and more broadly. The table 1 provides an over-
view of key data items with examples and issues germane 
to LMIC research and emergency care. Additionally, to 
help overcome barriers to high-quality systematised data 
being gathered and maintained in LMICs factors inclu-
sive of partnerships between academic institutions and 
healthcare systems, material support for data collection 
and linkage and incentives to overcome local opportu-
nity costs would be beneficial.9 Specific to clinical inter-
ventional and observational studies, documented metrics 
and measures should include structural and process 
measures that complement clinical and patient level 
outcome data.
Clinical outcomes
Clinical outcome measures vary according to study design 
and intervention type. However, in-hospital mortality 
is commonly collected as an objective, patient-centred 
outcome measure. In addition to the initial ED resusci-
tation, in-hospital mortality may be affected by timing of 
pre-ED interventions, post-ED care like surgical and crit-
ical care treatments. Due to the potential contribution 
of these factors, research using in-hospital mortality must 
take into account characteristics prior to ED presentation 
as well as post-ED care delivery so that studies are able to 
capture factors impacting outcomes across the continuum 
of treatment. Furthermore, understanding ED-specific 
mortality pertinent to the initial treatment period, espe-
cially through the first 24 hours of treatment, is an impor-
tant and rarely reported outcome that is greatly needed 
to inform and advance ED care provision. A common 
mortality metric in research is 90-day mortality, but due to 
resource limitations and barriers in many LMICs related 
to communication mechanisms, geographic distance 
and cultural practices, this commonly used outcome may 
not be feasible and more proximate outcomes should be 
used by LMIC researchers.10
In certain pathologies, mortality may be uncommon 
and not be the most relevant research measure for 
assessing emergency interventions.11 Thus, morbidity 
metrics can be key outcome measures for emergency care 
studies. Disability assessments and pragmatic evaluation 
of pre-illness versus post-illness functionality, along with 
abilities to perform social and vocational roles, should 
be considered by researchers in LMICs where there is 
limited information on such outcomes. Additionally, clin-
ical process measures could serve as surrogate outcomes 
of importance, by providing a dimension of under-
standing on resource availability and delivery.12 13 These 
clinical process measures should be considered at the 
outset of studies by LMIC emergency care researchers. 
For instance, the ordering and actual administration of 
intravenous fluid and blood products may be used as clin-
ical process measures in acute resuscitation research.
Emergency care research in LMICs should collect 
demographic, physiologic, laboratory and process 
measures that are reproducible. To ensure that key data 
are collected consistently and reliably, a parsimonious 
minimum required data set should be ubiquitously used 
with additional data gathered as needed, based on the 
specific research question. These required minimum 
data must include information regarding reasons for 
presentation for emergency care and ED outcomes.12 
Standardised clinical documentation forms, with uniform 
sets of minimum variables, would help to facilitate data 
consistency and acquisition. A smaller amount of data 
collected with completeness and accuracy is more valu-
able than larger inaccurate and incomplete data collec-
tions. Establishing a standard reporting of these aspects 
across LMIC ED research endeavours will facilitate 
pooling of data and subsequently be a powerful repos-
itory to be able to better understand patient character-
istics, disease burdens and outcomes within and across 
LMIC ED settings.
Cost-effectiveness
Metrics on cost-effectiveness need to be collected in 
research endeavours globally,13 especially in LMICs. 
In relation to HIV and TB in LMICs, there exists data 
on cost-effectiveness14; however, emergency care data is 
sparse. Research on acute myocardial infarctions from 
Latin America employing telemedicine referral pathways 
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Table 1 Overview of metrics and considerations for use
Data Items Examples Issues
Setting
Facility Prehospital
Facility (rural vs urban)
Different levels of data will be appropriate based 
on facility and the research capacity
Personnel Level of training
Proportion of providers across each levels of training
Large variability and must be thoroughly reported 
to ensure understanding and generalisability of 
findings
Equipment CT scan, sterile equipment, basic disposable items, for 
example, catheters, fluids, medications
Supply chain limitations and sustainability of 
access
Demographics
Country demographics Age and sex distinctions with generally younger 
populations with larger burdens of patients living with 
minimal resources
Demographic and risk transitions are poorly 
understood in LMICs and need to be well 
documented
Comorbidities Concurrence of infectious disease with non-infectious 
ones (eg, burdens of anaemia in injured patients)
Chronic diseases often unrecognised in LMIC
Difficulty to assess and categorise for existence 
and overlap
Processes
Prehospital care
ED
Admission as inpatient
Need for ICU
Discharge
ED length of stay
ED disposition
Inpatient length of stay
ICU availability and usage
Lack of clear definitions across physical structures 
and within single facilities
Laboratory testing
Point of care testing
Blood counts
TuberculosiB or HIV tests
ECG
Ultrasound
Availability of tests and types
Documentation of results
Interventions for 
treatments
Antimicrobials
Haemodynamic and respiratory support
Availability of equipment
Implementation costs
Implementation
Quality assurance
Uptake of and compliance with care algorithms Difficult to maintain sustainability without resource
Need for simple evaluation points
Outcomes
Mortality
Cause of death
ED based (initial treatment <24 hours)
In-hospital mortality and 30/60/90-day mortality
ED based outcomes not commonly collected
Posthospital follow-up difficult and resource 
intensive
Post-discharge function 
and morbidity
Quality of life and functionality assessments Difficult to collect
Cultural appropriateness
Provider acceptability Date from surveys, interviews, focus groups. Poor uptake resulting in lack of representativeness 
and inaccuracy
Uncommonly done in LMICs
Costing Fees incurred, lengths of stay, ICU usage, treatments Variability in costs across settings
ED, emergency department; ICU, intensive care unit; LMICs, low-income and middle-income countries.
to more well-resourced institutions has been shown to 
be cost-effective and represents a collaborative method-
ology that could be used in other LMICs.15 Also previ-
ously studied in emergency care research in Uganda 
is task shifting from more highly trained practitioners 
to other providers with less training and this has been 
found to have beneficial clinical impacts.16 Task shifting 
has also been put forth as cost-effective in community 
programmes for non-emergent health issues and study 
in emergency care settings is warranted.17 Although cost 
measurements are often difficult to attribute unless there 
is a fee-for-service system of care, researchers should be 
mindful of incorporating costing data into their work. 
Until comprehensive data systems are widely in place, a 
pragmatic approach in LMICs would be to use estimates 
of resource usage, such as length of stay across care 
venues, as well as medication administration, which in 
aggregate will provide a functional approximation of cost 
burden.
Human resource and infrastructure
Challenges in LMIC emergency care clinical research 
are amplified by human resource and logistical and 
infrastructural challenges.18 There are fewer trained 
researchers per capita in LMICs versus HICs despite the 
disproportionate disease burden. Additionally, academic 
groups and researchers in LMICs often have less guid-
ance from institutions, fewer mentorship resources and 
4 Aluisio AR, et al. BMJ Glob Health 2019;4:e001289. doi:10.1136/bmjgh-2018-001289
BMJ Global Health
box 1 injury Care research (Example of outcome 
metrics)
Injuries affect approximately 1 billion people per year,leading to 
over 5 million deaths and 138 million disability-adjusted life-years 
annually. Over 90% of this burdenfalls on those living in LMICs, 
where emergency andtrauma care resources are limited.5 35 36 
Despite the highmorbidity and mortality, funding for, and execution 
of, emergency care clinical research in LMICs has beenminimal. 
However, an exemplary body of work in injuryscience derived from 
the group implementing the CRASH trials does exist. This group runs 
large international randomised controlled trials that use pragmatic 
monitoring and data collection designs to evaluate large numbers 
of injured patients with a deliberate inclusion of LMIC settings. The 
Corticosteroid Randomisation After Significant Head Injury (CRASH) 
1 trial randomised>10 000 patients to corticosteroid or placebo 
after significant head injury and the Clinical Randomisation of an 
Antifibrinolytic in Significant Haemorrhage (CRASH) 2 trial randomised 
>20 000 patients to tranexamic acid or placebo after injury, both 
evaluating short-term mortality outcomes.37 38 This body of work 
highlights the role that appropriate and realistic outcome metrics 
serve inperforming emergency care clinical trials in LMICs andhow 
impactful results are attainable when comprehensiveresearch 
platforms are utilised and integrated intothe provision of emergency 
care.
less access to training to enhance research skills.19 20 In 
LMICs, there are high rates of turnover and migration 
of trained professionals, which inhibits longitudinal 
development at instructional and national levels.21 More-
over, emergency care providers often treat patients with 
high levels of severity and insufficient resources, further 
inhibiting their abilities to focus time on designing and 
performing clinical research.3
Capacity building in LMICs may be enhanced by 
training of emergency care clinicians and researchers 
in methods and logistical implementation appropriate 
for their settings. Mentored research training that takes 
into account cross-disciplinary and transgenerational 
personnel interactions is a key component to building 
research capacity in LMICs. Also important are devel-
oping a centralised institutional research agenda and 
establishing leadership at institutions in LMICs that can 
promote work at both system and individual levels and 
contribute to focused scientific goals. As not all LMICs 
can currently support such actions, collaboration either 
regionally or globally with institutions able to support 
education and mentoring of LMICs researches will be 
beneficial. An example of a successful longitudinal initia-
tive exists in Pakistan, where a collaborative research and 
training programme with institutional buy-in for injury 
prevention and treatment work has been developed and 
produces not only high-quality emergency care research 
but also an enhanced pool of local researchers and scien-
tific outputs.22 23
research ethics
Research ethics is of key importance in all medical 
research and especially in LMIC emergency care 
research where there is potentially limited protection for 
patients due to less regulatory infrastructure and limited 
guidance and oversight. This is further compounded by 
the paucity personnel formally trained in ethical frame-
works in many LMICs to support clinical trials and other 
research activities.24 The ethical complexities are exac-
erbated by barriers to patient follow-up and the high 
prevalence of vulnerable patients. Consequently, there 
is a need for development of ethical review boards with 
understanding of emergency care research in LMICs. 
Such development will require local institutional invest-
ment to foster individual well-trained researchers and 
more broadly research cultures, actions which could be 
bolstered through partnerships between institutions with 
existing systems to bridge the development of a strong 
foundation in research ethics. Partnerships of this nature 
would support promotion of emergency care research 
training as highlighted above and provide protection to 
the vulnerable patients needing acute emergency treat-
ments.
Technology
Technology is frequently not utilised to its maximum 
benefit to perform high=quality clinical emergency care 
research in LMICs.13 Specifically, there tends to be less 
comfort with and use of digital research data collection 
in LMICs. In addition, health systems often have less 
access to online resources and training programmes 
either due to financial or technological constraints. The 
provision of technological materials in LMIC settings to 
enhance awareness, usability and implementation via 
support from HIC partners and donors would assist in 
overcoming these barriers.
Although these barriers exist, leveraging technology 
represents a promising opportunity to improve emer-
gency care research in LMICs. Tools such as tablet-based 
data collection, text-based messaging for rapid follow-up 
and telemedicine can assist with patient screening, 
consent and enrolment and help streamline and stan-
dardise data collection and analysis leading to more 
efficient manuscript production and dissemination. 
Use of technology in training LMIC emergency care 
researchers, including distance learning and non-tra-
ditional media, is a minimally studied but potentially 
powerful area for development of human resources, as 
research educators and institutions from HICs can be 
strategically and efficiently utilised to train their counter-
parts in LMICs.25 Furthermore. partnering approaches 
could have far-reaching magnitude as they could be repli-
cated in multiple settings using the initially established 
processes in an economically efficient manner.
Additionally, use of innovation in emergency care 
research in LMICs could be better fostered through 
engagement of diverse personnel and social media, as 
has been demonstrated in medical hack-a-thons.26 Such 
events in India, Pakistan and Uganda have generated 
innovative ideas that have been used as launch pads for 
internally and externally funded research projects.27 
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Figure 1 Publications in emergency care clinical research by income strata over time.
These platforms are a novel model to support imple-
mentation of research that intersects with traditional and 
non-traditional clinical research personnel and designs.
Financial support
Funding for emergency care research in LMICs is insuf-
ficient. Across major research funders globally between 
2012 and 2016, there were only 115 supported projects for 
emergency care research in Africa, four in South America 
and 13 in Asia. This investment is compared with 1411 
projects in North American countries funded during the 
same time period.28 The minimal funding in emergency 
care clinical research is mirrored in deficient publication 
outputs from LMICs. As illustrated in figure 1, although 
there is an increasing frequency in the global trend in 
emergency care clinical research, the proportion occur-
ring in LMICs is a small minority and has only comprised 
2%–5% of published reports annually over the preceding 
decade (Average=3.2%, ±SD: 0.9%), with an even smaller 
proportion represented by clinical trials.
The disconnect between emergency health burdens 
and support for clinical research and scholarly outputs 
in LMICs illustrates the need for increased funding.29 
Emergency medicine is a new specialty in most LMICs; 
hence, it is difficult to identify local champions to engage 
in grant funding applications, further lowering the 
possibilities of securing research funding. To overcome 
these challenges, partnerships with researchers that are 
successful in securing funding should be developed with 
emergency care researchers in LMICs. Such partnerships 
could be with local, regional or international researchers 
who work in research both within and external to emer-
gency care provision, as the practice of emergency care 
allows for study of diverse disease processes. Funding for 
partnered research should include sources from conven-
tional mechanisms and as well non-traditional sources 
such as governmental organisations, non-governmental 
organisations, device manufacturers, pharmaceuticals 
and philanthropists. The dearth of funding must be 
addressed in order to improve outcomes among some 
of the most vulnerable and understudied populations 
globally.
kEy rEsEArCH FoCus ArEAs
As outlined in table 2, emergency care research can be 
characterised by the considerations of time, location 
and priority syndromes and diseases. Emergency care in 
LMICs differs from that in HICs in each of these dimen-
sions, as a result of infrastructure, density of compre-
hensive care facilities and differing burden of disease 
(including superimposed burden of communicable 
and non-communicable diseases resulting from the risk 
transition, eg, HIV infection complicating recovery in a 
patient with severe injuries). Relative to higher resource 
settings, initial illness presentation in LMICs tends to 
occur later in the disease course and at clinics with fewer 
resources than hospitals. Also, preclinical transport is 
more frequently ad hoc without formalised medical 
providers and support services, and care systems tend to 
be fragmented both horizontally and vertically.30 31 Emer-
gency care system development and capacity also tend to 
be relatively constrained, often mirroring health system 
development and capacity overall.
These considerations all factor into prioritisation 
for clinical emergency care research in LMIC settings. 
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Table 2 Dimensions of emergency care by resource setting
Emergency care 
dimension
Low resource
setting
Middle resource
setting
High resource
setting
Temporal Relatively long time from illness onset to 
presentation for care; distribution skewed 
to right
Variable time from illness onset to 
presentation for care; distribution with 
long tails
Shorter time from illness 
onset to presentation for care; 
distribution skewed to left
Spatial Supermajority of initial illness presentation 
to local acute intake areas of available 
health facilities with middle-level health 
providers.
Variable presentations across health 
system, from local clinics to district 
hospitals
Supermajority of initial illness 
presentations to hospital-based 
emergency departments with 
physician staff
Health burdens 
and priorities
Substantial burden of disease related 
to acute infectious disease, injuries, 
high burden of paediatric illness; certain 
settings may have unusually or uniquely 
high prevalence of certain exposures or 
conditions (eg, Ebola, extreme heat)
Variable range of threats across 
settings; larger overall burden 
of disease associated with non-
communicable and communicable 
disease related to risk transition
Substantial proportion of 
disease related to acute 
exacerbations of chronic 
disease
System Capacity
(clinical care and 
research)
Lower average levels of training among 
care providers, lower per capita provider 
rates, lower research capacity
Variable skill and capacity, typically 
concentrated in urban areas; variable 
research capacity
Higher per capita rates of 
physician coverage, relatively 
high research capacity
box 2 sepsis research in Africa (Example of key focus 
area)
The emergency diagnosis and management of sepsis is an area 
of LMIC research that has dimensions with unique characteristics 
as compared with that in HICs and that could serve as a model for 
research with crucial importance.39 Mortality due to sepsis is more 
common in LMICs, and patients with sepsis often present to health 
centreswith limited resources in advanced shock states. Additionally, 
controlled trial data from Africa assessing the application of sepsis 
treatments based on HIC protocols hasdemonstrated worse outcomes. 
In a trial by Maitland etal, higher mortality in paediatric patients 
with sepsis wasassociated with intravenous fluid bolus therapy. 
Similarly,trial data among adult patients with sepsis from Zambia 
found that protocol-based resuscitation with administration of 
intravenous fluids and vasopressors were associated with a higher 
in-hospital mortality compared withusual care.32 33 As such, research 
aimed at identifying,triaging and treating patients with sepsis early 
and appropriatelyis of high value. Such research could entail usingvital 
signs or simple clinical assessments such as the QuickSepsis-
Related Organ Failure Assessment score and integrating these with 
accessible low-cost technology, suchas oxygen saturation monitoring, 
to determine setting appropriate risk stratification algorithms.40 41 
Subsequently,these pathways could be linked to context-appropriate 
bundles of care which could be studied as an area of investigation 
pertinent to patient-centred outcomes.Studies to identify patients with 
infections who requireadmission versus those who can be managed 
as outpatientsmay also ease the burden in the lower-resourcedED. 
These questions could be approached using iterativestudy designs of 
simple cohort studies followed by trialslooking at outcomes in LMIC 
settings.
Identifying priorities is context specific and depends 
on disease burden (certain disease processes may be 
more prevalent in specific areas such as HIV or Ebola 
Virus Disease), resource availability and system struc-
ture, among others. There is wide variability, even 
within specific LMICs, and this can further increase the 
complexity of specific research prioritisation efforts. As 
a result, in many LMIC settings, identifying and evalu-
ating innovative ways to improve the systems and quality 
of care are a crucial part of a broader research agenda. 
Similarly, reducing barriers and constraints to accessing 
care, which can be assessed using metrics such as time 
between illness development and presentation for care, is 
important, particularly in rural areas with disproportion-
ately limited capacity. Overlaying assessment of access 
and epidemiology of priority health threats in terms of 
disease burden and amenability to intervention can help 
guide infrastructure and research investment. In many 
cases, emergency care research in LMICs has focused 
on translation and implementation of practices deemed 
efficacious in HICs to LMIC settings without taking into 
account the appropriate systems and disease factors that 
are present, as has been demonstrated in sepsis care in 
Africa.32 33
In the majority of settings, emergency care of the 
undifferentiated patient is driven by chief complaint and 
syndromic presentations rather than pre-existing diag-
noses. In LMIC settings, this approach has often resulted 
in a focus on identifying syndromic presentations, which 
de-emphasises the need for expensive and scarce labora-
tory and imaging services and promotes care directed by 
common final pathological states (eg, immune dysregu-
lation and shock), as these are responsible for the largest 
burdens of morbidity and mortality in LMIC emergency 
care settings.6 Moreover, these final common states may 
lend themselves to treatment with simple and inexpen-
sive bundled interventions, which can be taught to and 
delivered by providers with limited but focused skills and 
training.34 Priorities for choosing intervention bundles 
are context specific and frequently chosen based on 
pragmatic criteria for reducing morbidity and mortality 
burdens and interaction with cost-effectiveness consid-
erations (ie, interventions with a low number-needed-to-
treat and an appropriate cost-effectiveness estimate under 
the constraints of the specific LMICs’ ability to support 
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the intervention). Accordingly, LMIC researchers and 
funders of such research should adopt a framing para-
digm, which focuses on the impact and cost-effectiveness 
in the development, funding and execution of emer-
gency care studies.
There is a paucity of implementation research, espe-
cially in emergency care from LMICs. Addressing this 
data void will be fundamental to ensure the appropriate-
ness and success of interventions moving forward. For 
implementation studies, acceptability to practitioners 
and patients should be a central focus along with feasi-
bility based on existing resources in the specific LMIC 
settings of interest. For acceptability evaluations, varying 
approaches have been used including focus groups, elec-
tronic surveys and interviews. As such work is carried out, 
cultural issues implicit in each approach should be taken 
into consideration and leveraged to ensure the best 
possible data are attained.
ConCLusions
Emergency care clinical research has substantial 
potential to impact overall morbidity and mortality in 
LMICs. There are, however, addressable constraints to 
conducting clinical research in LMICs including: (1) 
lack of agreed on, relevant and reproducible measures; 
(2) barriers in funding, resources, training and capacity; 
(3) ethical constraints and (4) disconnect in recognised 
emergency care dimensions.
In light of these challenges, the following approaches 
should be considered when developing and conducting 
high-quality emergency care clinical research in LMICs. 
Utilisation of standardised outcome measures such as 
mortality and the consistent collection of parsimonious 
minimum data sets. Systematic incorporation of struc-
tural and human capacity development and the lever-
aging of technology and international collaborations to 
catalyse development and improve equity in emergency 
care research. Advocacy for funding from traditional and 
non-traditional sources using collaborative partnership 
should be strengthened. Research foci based on disease 
burdens and syndromic presentations responsible for the 
largest contributions to morbidity and mortality in emer-
gency care settings must be prioritised. Research findings 
from LMICs should be translated into practice and policy 
through education and engagement of local stakeholders 
which will support knowledge dissemination and integra-
tion into care delivery.
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